Chronic Low Grade Inflammation in Pathogenesis of PCOS
Open accessThe DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a one of the most common endocrine disorders, with a prevalence rate of 5–10% in reproductive aged women. It’s characterized by (1) chronic anovulation, (2) biochemical and/or clinical hyperandrogenism, and (3) polycystic ovarian morphology. PCOS has significant clinical implications and can lead to health problems related to the accumulation of adipose tissue, such as obesity, insulin resistance, metabolic syndrome, and type 2 diabetes. There is also evidence that PCOS patients are at higher risk of cardiovascular diseases, atherosclerosis, and high blood pressure. Several studies have reported the association between polycystic ovary syndrome (PCOS) and low-grade chronic inflammation. According to known data, inflammatory markers or their gene markers are higher in PCOS patients. Correlations have been found between increased levels of C-reactive protein (CRP), interleukin 18 (IL-18), tumor necrosis factor (TNF-α), interleukin 6 (IL-6), white blood cell count (WBC), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) in the PCOS women compared with age- and BMI-matched controls. Women with PCOS present also elevated levels of AGEs and increased RAGE (receptor for advanced glycation end products) expression. This chronic inflammatory state is aggravating by obesity and hyperinsulinemia. There are studies describing mutual impact of hyperinsulinemia and obesity, hyperandrogenism, and inflammatory state. Endothelial cell dysfunction may be also triggered by inflammatory cytokines. Many factors involved in oxidative stress, inflammation, and thrombosis were proposed as cardiovascular risk markers showing the endothelial cell damage in PCOS. Those markers include asymmetric dimethylarginine (ADMA), C-reactive protein (CRP), homocysteine, plasminogen activator inhibitor-I (PAI-I), PAI-I activity, vascular endothelial growth factor (VEGF) etc. It was also proposed that the uterine hyperinflammatory state in polycystic ovary syndrome may be responsible for significant pregnancy complications ranging from miscarriage to placental insufficiency. In this review, we discuss the most importance evidence concerning the role of the process of chronic inflammation in pathogenesis of PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“COCs also exacerbate the inflammatory state present in these patients, which is likely related to increased aldosterone–renin ratio and CRP [12,14].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“The release of inflammatory markers is associated with long-term metabolic complications and high cardiovascular risk [12].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Macrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314
Adapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
Chronic Inflammation in Obesity and the Metabolic Syndrome
Monteiro, R., & Azevedo, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/289645 · Cited by 1,186 · cited 1×
“Obesity is a metabolic condition characterized by chronic inflammation state with higher pro-inflammatory cytokines, chemokines, and oxidative stress (OS) markers levels [5,6].”
BackgroundChronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Metabolic Inflammation and Insulin Resistance in Obesity
Wu, H., & Ballantyne, C. M. (2020) · Circulation Research · doi:10.1161/circresaha.119.315896 · Cited by 1,059
Research works printed but not linked: 1
- Burhans, 2018, Contribution of AT inflammation to the development of T2D mellitus, Compr. Physiol., 9, 1
Cited by
Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
Sadeghi, H. M., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., & Abdollahi, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020583 · Cited by 445
Armanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
Zhou, M., Zhang, Y., Shi, L., Li, L., Zhang, D., Gong, Z., & Wu, Q. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107282 · Cited by 253
Yang, J., & Chen, C. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0342 · Cited by 169
Fiorentino, G., Cimadomo, D., Innocenti, F., Soscia, D., Vaiarelli, A., Ubaldi, F. M., Gennarelli, G., Garagna, S., Rienzi, L., & Zuccotti, M. (2023) · Human Reproduction Update · doi:10.1093/humupd/dmac031 · Cited by 176
Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
Su, P., Chen, C., & Sun, Y. W. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01621-6 · Cited by 198
The latest reports and treatment methods on polycystic ovary syndrome
Stańczak, N. A., Grywalska, E., & Dudzińska, E. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2357737 · Cited by 193
Dysregulation of immune response in PCOS organ system
Wang, J., Yin, T., & Liu, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1169232 · Cited by 183
Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome
Deng, H., Chen, Y., Xing, J., Zhang, N., & Xu, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1470283 · Cited by 168
Guo, Y., Xue, L., Tang, W., Xiong, J., Chen, D., Dai, Y., Wu, C., Wei, S., Dai, J. Y., Wu, M., et al. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmae020 · Cited by 144
OXIDATIVE STRESS AND REPRODUCTIVE FUNCTION: Oxidative stress in polycystic ovary syndrome
Rudnicka, E., Duszewska, A. M., Kucharski, M., Tyczyński, P., & Smolarczyk, R. (2022) · Reproduction · doi:10.1530/rep-22-0152 · Cited by 147
Self-citationImmune regulation in polycystic ovary syndrome
Luan, Y., Zhang, L., Peng, Y., Li, Y., Liu, R., & Yin, C. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.04.234 · Cited by 130
Lonardo, M. S., Cacciapuoti, N., Guida, B., Lorenzo, M. D., Chiurazzi, M., Damiano, S., & Menale, C. (2024) · Current Obesity Reports · doi:10.1007/s13679-023-00531-2 · Cited by 132
Advanced Glycation End Products in Disease Development and Potential Interventions
Zhang, Y., Zhang, Z., Tu, C., Chen, X., & He, R. (2025) · Antioxidants · doi:10.3390/antiox14040492 · Cited by 141
The Role of Lifestyle Interventions in PCOS Management: A Systematic Review
Gautam, R., Maan, P., Jyoti, A., Kumar, A., Malhotra, N., & Arora, T. (2025) · Nutrients · doi:10.3390/nu17020310 · Cited by 115
Insulin Resistance in Polycystic Ovarian Syndrome
Purwar, A., & Nagpure, S. (2022) · Cureus · doi:10.7759/cureus.30351 · Cited by 152
Polycystic Ovary Syndrome Fuels Cardiovascular Inflammation and Aggravates Ischemic Cardiac Injury
Gao, L., Zhao, Y., Wu, H., Lin, X.-H., Guo, F., Li, J., Long, Y., Zhou, B., She, J., Zhang, C., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065827 · Cited by 111
Fabozzi, G., Verdone, G., Allori, M., Cimadomo, D., Tatone, C., Stuppia, L., Franzago, M., Ubaldi, N., Vaiarelli, A., Ubaldi, F. M., et al. (2022) · Nutrients · doi:10.3390/nu14091918 · Cited by 106
Barrea, L., Muscogiuri, G., Pugliese, G., de Alteriis, G., Colao, A., & Savastano, S. (2021) · Nutrients · doi:10.3390/nu13113925 · Cited by 99
“Correlations have been found between increased levels of CRP and other markers of inflammation in the PCOS women compared with age- and BMI-matched controls [1].”
BackgroundResultAdvances in the study of the correlation between insulin resistance and infertility
Lei, R., Chen, S., & Li, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1288326 · Cited by 92
A review on critical appraisal and pathogenesis of polycystic ovarian syndrome
Hajam, Y. A., Rather, H., Neelam, N., Kumar, R., Basheer, M., & Reshi, M. S. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100162 · Cited by 104
Awonuga, A. O., Camp, O. G., & Abu‐Soud, H. M. (2023) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-023-01159-6 · Cited by 93
Zhan, W., Tang, W., Shen, X., Xu, H., & Zhang, J. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.137463 · Cited by 89
Szukiewicz, D., Trojanowski, S., Kociszewska, A., & Szewczyk, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314663 · Cited by 91
Polycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach
Nautiyal, H., Imam, S. S., Alshehri, S., Ghoneim, M. M., Afzal, M., Alzarea, S. I., Güven, E., Al-Abbasi, F. A., & Kazmi, I. A. (2022) · Biomedicines · doi:10.3390/biomedicines10030540 · Cited by 99
Subclinical cardiovascular disease and polycystic ovary syndrome
Gomez, J. M. D., VanHise, K., Stachenfeld, N. S., Chan, J. L., Merz, C. N. B., & SHUFELT, C. L. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.02.028 · Cited by 85
Polycystic Ovary Syndrome (PCOS): Symptoms, Causes, and Treatment
Bai, H., Ding, H., & Wang, M. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5105126 · Cited by 88
Macrophages: a double-edged sword in female reproduction and disorders
Park, M., Kim, Y. S., & Song, H. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01392-6 · Cited by 82
Marouf, B. H., Dana, O. I., Hassan, A. H., & Ali, O. J. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s379725 · Cited by 73
Lai, Y.-C., Ye, Z., Mu, L., Zhang, Y., Long, X., Zhang, C., Li, R., Zhao, Y., & Qiao, J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac281 · Cited by 83
The Complex Roles of Adipokines in Polycystic Ovary Syndrome and Endometriosis
Schüler‐Toprak, S., Ortmann, O., Buechler, C., & Treeck, O. (2022) · Biomedicines · doi:10.3390/biomedicines10102503 · Cited by 74
Zhou, L., Qu, H., Yang, L., & Shou, L. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01500-5 · Cited by 66
Feng, Y., Tang, Z., & Zhang, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115470 · Cited by 63
Liu, M., Guo, S., Li, X., Tian, Y., Yu, Y., Tang, L., Sun, Q., Zhang, T., Fan, M., Zhang, L., et al. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s484531 · Cited by 68
Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers
Dey, R., Bhattacharya, K., Basak, A. K., Paul, N., Bandyopadhyay, R., Chaudhuri, G. R., Purkait, M. P., Bhattacharjee, A., Bose, C., Shukla, N., et al. (2023) · Middle East Fertility Society Journal · doi:10.1186/s43043-023-00158-2 · Cited by 69
Reconsidering the Polycystic Ovary Syndrome (PCOS)
Gleicher, N., Darmon, S. K., Patrizio, P., & Barad, D. H. (2022) · Biomedicines · doi:10.3390/biomedicines10071505 · Cited by 61
Mukherjee, A. G., Wanjari, U. R., Kannampuzha, S., Murali, R., Namachivayam, A., Ganesan, R., Dey, A., Babu, A., Renu, K., Vellingiri, B., et al. (2023) · Metabolites · doi:10.3390/metabo13010129 · Cited by 64
Advancements in lead therapeutic phytochemicals polycystic ovary syndrome: A review
Luo, E., Jiang, H., Chen, W., Wang, Y., Tang, M., Guo, W., Diao, H., Cai, N.-Y., Yang, X., Bian, Y., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1065243 · Cited by 61
Reprogram to heal: Macrophage phenotypes as living therapeutics
Ghamangiz, S., Jafari, A., Maleki, H., Azimi, H., & Mazloomi, E. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123601 · Cited by 56
Polycystic ovary syndrome and its management: In view of oxidative stress
Bhattacharya, K., Dey, R., Sen, D., Paul, N., Basak, A. K., Purkait, M. P., Shukla, N., Chaudhuri, G. R., Bhattacharya, A., Maiti, R., et al. (2024) · BioMolecular Concepts · doi:10.1515/bmc-2022-0038 · Cited by 65
Liu, J., Yang, Y., He, Y., Feng, C., Ou, H., Yang, J., Chen, Y., You, F., Shao, B., Bao, J., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.116046 · Cited by 52
Minerals and the Menstrual Cycle: Impacts on Ovulation and Endometrial Health
Kapper, C., Oppelt, P., Ganhör, C., Gyunesh, A. A., Arbeithuber, B., Stelzl, P., & Rezk, M. (2024) · Nutrients · doi:10.3390/nu16071008 · Cited by 66
Zhang, Y., Lin, Y., Li, G., Yuan, Y., Wang, X., Li, N., Xiong, C., Yang, Y., Ma, Y., Zhang, Z., et al. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad032 · Cited by 53
Oxidative Stress and MicroRNAs in Endothelial Cells under Metabolic Disorders
Minjares, M., Wu, W. G., & Wang, J. (2023) · Cells · doi:10.3390/cells12091341 · Cited by 47
Salehi, S., Allahverdy, J., Pourjafar, H., Sarabandi, K., & Jafari, S. M. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10223-5 · Cited by 51
Batóg, G., Dołoto, A., Bąk, E., Piątkowska‐Chmiel, I., Krawiec, P., Pac‐Kożuchowska, E., & Herbet, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1211231 · Cited by 50
Geng, L., Yang, X., Sun, J., Ran, X., Zhou, D., Ye, M., Li, W., Wang, R., & Chen, M. (2025) · Advanced Science · doi:10.1002/advs.202412558 · Cited by 49
Xu, Q., Zhang, J., Lu, Y., & Wu, L. Y. (2024) · iScience · doi:10.1016/j.isci.2024.108783 · Cited by 50
Szmidt, M. K., Granda, D., Madej, D., Sicinska, E., & Kałuża, J. (2023) · Nutrients · doi:10.3390/nu15092131 · Cited by 43
Zhang, W., & Wu, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-56970-x · Cited by 42
Srnovršnik, T., Virant‐Klun, I., & Pinter, B. (2023) · Antioxidants · doi:10.3390/antiox12071398 · Cited by 45
Mączka, K., Stasiak, O., Przybysz, P., Grymowicz, M., & Smolarczyk, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179391 · Cited by 38
Self-citationAhmed, M., Riaz, U., Lv, H., Amjad, M., Ahmed, S., Ali, S., Ghani, M. U., Hua, G., & Yang, L. (2024) · Antioxidants · doi:10.3390/antiox14010039 · Cited by 38
Zhang, J., Zhang, H., Xin, X., Zhu, Y., Yang, Y., & Li, D. (2022) · Nutrients · doi:10.3390/nu14194128 · Cited by 40
Gut microbiota: an emerging target connecting polycystic ovarian syndrome and insulin resistance
Mei, Y., Li, W., Wang, B., Chen, Z., Wu, X., Lin, Y., & Wang, M. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1508893 · Cited by 38
Glycemic Index and Glycemic Load Estimates in the Dietary Approach of Polycystic Ovary Syndrome
Manta, A., Paschou, S. Α., Isari, G., Mavroeidi, I., Kalantaridou, S., & Peppa, Μ. (2023) · Nutrients · doi:10.3390/nu15153483 · Cited by 38
Yan, S., Gao, Z., Ding, J., Chen, S., Wang, Z., Jin, W., Qu, B., Zhang, Y., Yang, L., Guo, D., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02182-w · Cited by 35
Scarfò, G., Daniele, S., Fusi, J., Gesi, M., Martini, C., Franzoni, F., Cela, V., & Artini, P. G. (2022) · Biomedicines · doi:10.3390/biomedicines10061305 · Cited by 45
Effects of intestinal flora on polycystic ovary syndrome
Liu, J., Liu, Y., & Li, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1151723 · Cited by 43
Polycystic ovary syndrome and adipose tissue
Lemaître, M., Christin‐Maître, S., & Kerlan, V. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.11.004 · Cited by 40
Chen, Y., Xie, M., Wu, S., Deng, Z., Tang, Y., Guan, Y., Ye, Y., He, Q., & Li, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1426517 · Cited by 38
Zhang, J., Ding, N., Xin, W., Yang, X., & Wang, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.871945 · Cited by 39
Fang, X., Ma, L., Wang, Y., Ren, F., Yu, Y., Yuan, Z., Wei, H., Zhang, H., & Sun, Y. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003231 · Cited by 32
The Effect on Inflammation of Adherence to the Mediterranean Diet in Polycystic Ovary Syndrome
Dazıroğlu, M. E. Ç., & Tek, N. A. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00451-6 · Cited by 37
Jabarpour, M., Amidi, F., Aleyasin, A., Nashtaei, M. S., & Saedi-Marghmaleki, M. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18464 · Cited by 34
Adipose Tissue Plasticity: A Comprehensive Definition and Multidimensional Insight
Mo, Y.-Y., Han, Y., Xu, S., Jiang, H., Wu, H., Cai, J., Li, L., Bu, Y., Xiao, F., Liang, H., et al. (2024) · Biomolecules · doi:10.3390/biom14101223 · Cited by 34
Hou, S., Tian, Z., Zhao, D., Liang, Y. J., Dai, S., Ji, Q., Fan, Z., Liu, Z., Liu, M., & Yang, Y. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200800 · Cited by 30
Jie, S., Wang, S., Wang, A., Li, F., Zhang, J., Wang, J., Lv, R., Chen, H., Mu, X., Zhang, K., et al. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-023-01183-6 · Cited by 31
Luo, M., Yang, X., Zhou, M., Zhang, J., Yu, B., Lian, H., & Ye, J. (2024) · iScience · doi:10.1016/j.isci.2024.111028 · Cited by 30
The influence of sex on neuroimmune communication, pain, and physiology
Alexander, S. N., Green, A. R., Debner, E. K., Freitas, L. E. R., Abdelhadi, H. M. K., Szabo-Pardi, T. A., & Burton, M. D. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00660-w · Cited by 32
Inflammasomes in human reproductive diseases
Chen, Y., Miao, C., Zhao, Y., Yang, L., Wang, R., Shen, D., Ren, N., & Zhang, Q. (2023) · Molecular Human Reproduction · doi:10.1093/molehr/gaad035 · Cited by 32
He, S., Li, H., Zhang, Q., Zhao, W., Li, W., Dai, C., Li, B., Cheng, J., Wu, S., Zhou, Z., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155456 · Cited by 30
Moslehi, N., Zeraattalab-Motlagh, S., Rahimi Sakak, F., Shab-Bidar, S., Tehrani, F. R., & Mirmiran, P. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuac075 · Cited by 28
Chamanara, S., Hozouri, V., & Irandoost, E. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23592 · Cited by 28
Lee, D., Jo, H., Jang, Y., Bae, S., Agura, T., Kang, D., Kang, M., Kim, Y., Cho, N., Kim, Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010678 · Cited by 28
Risk factors for insulin resistance related to polycystic ovarian syndrome in Iranian population
Mansour, A., Mirahmad, M., Mohajeri‐Tehrani, M. R., Jamalizadeh, M., Hosseinimousa, S., Rashidi, F., Asili, P., & Sajjadi‐Jazi, S. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-37513-2 · Cited by 34
Sikiru, A. B., Adeniran, M. A., Akinola, K., Behera, H., Kalaignazhal, G., & Egena, S. S. A. (2023) · Middle East Fertility Society Journal · doi:10.1186/s43043-023-00142-w · Cited by 29
Reproductive aging in biological females: mechanisms and immediate consequences
Muhammad, Y. A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1658592 · Cited by 29
Bizoń, A., Tchórz, A., Madej, P., Leśniewski, M., Wójtowicz, M., Piwowar, A., & Franik, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092548 · Cited by 26
Zhang, S., He, H., Wang, Y., Wang, X., & Liu, X. (2023) · Scientific Reports · doi:10.1038/s41598-023-34746-z · Cited by 30
Lin, Y., Wang, G., Li, Y., Yang, H., Zhao, Y., Liu, J., & Mu, L. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad376 · Cited by 28
Li, R., Hu, R. M., Huang, Y., Li, D., Ma, X., & Yang, Y. (2023) · Endocrine · doi:10.1007/s12020-023-03553-x · Cited by 26
Polycystic Ovarian Syndrome: a Risk Factor for Cardiovascular Disease
Alvarez, Y. R., Pico, M. G., Ashokprabhu, N. D., Abou-Amro, K., Bailey, S., Pung, E., Oberholster, E., & Quesada, O. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01168-1 · Cited by 26
Paeoniflorin alleviates liver injury in hypercholesterolemic rats through the ROCK/AMPK pathway
Liu, T., Zhang, N., Kong, L., Chu, S., Zhang, T., Yan, G., Ma, D., Dai, J., & Ma, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.968717 · Cited by 25
Kalsekar, A. S., Abdelrahim, D. N., & Faris, M. E. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1362226 · Cited by 21
Merza, W. M., Yaseen, A. K., & Mahmood, M. A. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106773 · Cited by 25
Role of the NLRP3 inflammasome in gynecological disease
Zheng, X., Zhao, D., Jin, Y., Liu, Y., & Liu, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115393 · Cited by 24
Bogdan-Andreescu, C. F., Banateanu, A. M., Albu, C.-C., Poalelungi, C.-V., Botoaca, O., Damian, C. M., Dȋră, L. M., Albu, Ş.-D., Brăila, M. G., Cadâr, E., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12112569 · Cited by 24
The Role of the Liver in the Pathophysiology of PCOS: A Literature Review
Alhermi, A., Perks, H., Vadassery, V. N., Altahoo, N., Atkin, S. L., & Butler, A. E. (2025) · Biomolecules · doi:10.3390/biom15010051 · Cited by 27
Yang, H., Wang, G., Liu, C., Ding, L., Li, Y., Chen, Y., Teng, Y., Xu, Z., Ye, Z., Zhao, Y., et al. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.11.1287 · Cited by 24
Yang, J.-P., Ullah, A., Su, Y.-N., Otoo, A., Adu‐Gyamfi, E. A., Feng, Q., Wang, Y., Wang, M., & Ding, Y. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad048 · Cited by 24
Zuo, L., Hai, Y., Zhang, R., Zuo, B., Tian, J., Li, P., Ke, X., Wang, M., Ren, L., Li, X., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175825 · Cited by 27
Chen, W., Miao, J., Chen, J., & Chen, J. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-024-01583-1 · Cited by 24
Mahabamunuge, J., Sekula, N. M., Lepore, C., Kudrimoti, M., Upadhyay, A., Alshowaikh, K., Li, H. J., Seifer, D. B., & AlAshqar, A. (2025) · Biomedicines · doi:10.3390/biomedicines13030709 · Cited by 30
Posttranslational modifications in pathogenesis of PCOS
Wei, H., Huo, P., Liu, S., Huang, H., & Zhang, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1024320 · Cited by 26
Chełchowska, M., Jurczewska, J., Gajewska, J., Mazur, J., Szostak-Węgierek, D. E., Rudnicka, E., & Ambroszkiewicz, J. (2023) · Antioxidants · doi:10.3390/antiox12030730 · Cited by 23
Self-citationContribution of environmental, genetic and epigenetic factors to obesity-related metabolic syndrome
Ghosh, S., Dhar, S., Bhattacharjee, S., & Bhattacharjee, P. (2023) · The Nucleus · doi:10.1007/s13237-023-00420-y · Cited by 23
Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes
Moulana, M. (2023) · Life · doi:10.3390/life13041010 · Cited by 27
Li, Z., Geng, H., Ye, C., Cao, L., Qin, R., Chen, K., Fu, Y., & Liu, J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114038 · Cited by 25
Dong, Y., Yang, S., Zhang, S., Zhao, Y., Li, X., Han, M., Gai, Z., & Zou, K. (2025) · mSphere · doi:10.1128/msphere.00887-24 · Cited by 26
Metadata
- Authors
- Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B.
- Affiliations
- Medical University of Warsaw (PL)
- Warsaw University of Life Sciences (PL)
- Department of Gynaecological Endocrinology, Poznan University of Medical Sciences, 60-535 Poznan, Poland
- Corresponding author
- Rudnicka, Ewa
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-04-06
- Volume
- 22
- Issue
- 7
- Pages
- 3789
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8038770
- OpenAlex
- W3145310045
- Cited by
- 680
- References
- 99
- Citations by year
- 2026: 152 · 2025: 172 · 2024: 165 · 2023: 112 · 2022: 74 · 2021: 5
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, low-grade inflammation, inflammatory cytokines, C-reactive protein, advanced glycation end products, RAGE, hyperinsulinemia, obesity, endothelial dysfunction, oxidative stress, cardiovascular risk, pregnancy complications, hyperandrogenism, insulin resistance
- MeSH terms
- Aging, C-Reactive Protein, Chronic Disease, Diabetes Mellitus, Type 2, Female, Humans, Inflammation, Obesity, Polycystic Ovary Syndrome, Cytokines, Metabolic Syndrome, Endothelial Cells, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.